| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVVE | Common Stock | Purchase | $50,000 | +25,000 | +38% | $2.00* | 90,608 | 02 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVVE | Warrants to Purchase Common Stock | Award | +25,000 | +108% | 48,109 | 02 Feb 2024 | Common Stock | 25,000 | $2.00 | Direct | F1, F2 | ||
| transaction | NVVE | Warrants to Purchase Common Stock | Award | +25,000 | +52% | 73,109 | 02 Feb 2024 | Common Stock | 25,000 | $2.00 | Direct | F1, F3, F4 | ||
| transaction | NVVE | Warrants to Purchase Common Stock | Award | +25,000 | +34% | 98,109 | 02 Feb 2024 | Common Stock | 25,000 | $2.00 | Direct | F1, F5, F6 |
| Id | Content |
|---|---|
| F1 | The common stock, Series A warrants, Series B warrants and Series C warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 2, 2024. |
| F2 | Series A Warrants to purchase Common Stock |
| F3 | Series B Warrants to purchase Common Stock. |
| F4 | Series B warrants will expire on November 2, 2024 |
| F5 | Series C Warrants to purchase Common Stock |
| F6 | The Series C warrants to purchase Common Stock may only be exercised to the extent and in proportion to the holder of the Series C warrants exercising its corresponding Series B warrants to purchase Common Stock. The Series C warrants to purchase Common Stock expire fire years from the date of issuance, however, provided that to the extent and in proportion to the holder of Series C warrants not exercising its corresponding Series B warrants, such Series C warrants will expire on November 2, 2024. |